Neuro Recovery Group AG – Trademark Portfolio
Entity Type: 25
Neuro Recovery Group AG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CERENEO.
Seestrasse 18
CH-6354 Vitznau
Showing of trademarks Trademarks
Trademark Classifications
Neuro Recovery Group AG's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Education; providing of training; entertainment; sporting and cultural activities
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Neuro Recovery Group AG have?
Neuro Recovery Group AG has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered.
What trademark classes does Neuro Recovery Group AG file in?
Neuro Recovery Group AG files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Neuro Recovery Group AG's most well-known trademarks?
Neuro Recovery Group AG's registered trademark portfolio includes well-known marks such as CERENEO. These are among 1 currently registered trademark in the portfolio.
What is Neuro Recovery Group AG's trademark registration success rate?
Neuro Recovery Group AG has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.